SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board
SS Innovations International, Inc. (OTC: SSII) has announced the addition of Tim Adams to its Board of Directors as an Independent Director. Mr. Adams, a healthcare executive with over 40 years of experience, currently serves as a Regional Operating Officer at Ascension, overseeing high-growth Horizontal Business Units. His extensive background includes leadership roles at major healthcare providers such as Tenet Healthcare , Community Health Systems, and HCA.
Dr. Sudhir Srivastava, SS Innovations Chairman and CEO, expressed enthusiasm about Mr. Adams joining during a phase of global growth. The company recently launched the SSI Mantra 3, an advanced surgical robotic system designed for multi-specialty usage. SS Innovations is currently seeking FDA approval and anticipates receiving marketing approval in the second half of 2025.
SS Innovations International, Inc. (OTC: SSII) ha annunciato l'aggiunta di Tim Adams al suo Consiglio di Amministrazione come Direttore Indipendente. Il signor Adams, un dirigente nel settore della salute con oltre 40 anni di esperienza, ricopre attualmente il ruolo di Direttore Operativo Regionale presso Ascension, supervisionando le Unità Aziendali Orizzontali ad alta crescita. La sua vasta esperienza include ruoli di leadership presso importanti fornitori di assistenza sanitaria come Tenet Healthcare, Community Health Systems e HCA.
Il Dott. Sudhir Srivastava, Presidente e CEO di SS Innovations, ha espresso entusiasmo riguardo l'ingresso del signor Adams in un periodo di crescita globale. L'azienda ha recentemente lanciato il SSI Mantra 3, un avanzato sistema robotico chirurgico progettato per un uso multi-specialistico. SS Innovations sta attualmente cercando l'approvazione della FDA e prevede di ricevere l'approvazione al marketing nella seconda metà del 2025.
SS Innovations International, Inc. (OTC: SSII) ha anunciado la incorporación de Tim Adams a su Junta Directiva como Director Independiente. El señor Adams, un ejecutivo del sector salud con más de 40 años de experiencia, actualmente se desempeña como Director Regional de Operaciones en Ascension, supervisando Unidades de Negocio Horizontales de alto crecimiento. Su amplia experiencia incluye roles de liderazgo en importantes proveedores de atención médica como Tenet Healthcare, Community Health Systems y HCA.
El Dr. Sudhir Srivastava, Presidente y CEO de SS Innovations, expresó su entusiasmo por la llegada del señor Adams en una fase de crecimiento global. La empresa lanzó recientemente el SSI Mantra 3, un avanzado sistema robótico quirúrgico diseñado para su uso en múltiples especialidades. SS Innovations busca actualmente la aprobación de la FDA y anticipa recibir la aprobación de marketing en la segunda mitad de 2025.
SS Innovations International, Inc. (OTC: SSII)는 Tim Adams를 독립 이사로 이사회에 추가했다고 발표했습니다. Adams 씨는 40년 이상의 경력을 가진 의료 임원으로, 현재 Ascension에서 지역 운영 책임자로 재직하며 고성장 수평 사업 부서를 감독하고 있습니다. 그는 Tenet Healthcare, Community Health Systems 및 HCA와 같은 주요 의료 제공업체에서의 리더십 역할을 포함한 폭넓은 배경을 가지고 있습니다.
SS Innovations의 의장이자 CEO인 Sudhir Srivastava 박사는 Adams 씨가 글로벌 성장의 단계에서 합류하게 되어 기쁘다고 밝혔습니다. 이 회사는 최근 다전문 사용을 위해 설계된 고급 외과 로봇 시스템인 SSI Mantra 3를 출시했습니다. SS Innovations는 현재 FDA 승인을 요청하고 있으며, 2025년 하반기에 마케팅 승인을 받을 것으로 예상하고 있습니다.
SS Innovations International, Inc. (OTC: SSII) a annoncé l'ajout de Tim Adams à son Conseil d'Administration en tant que Directeur Indépendant. M. Adams, un dirigeant dans le secteur de la santé avec plus de 40 ans d'expérience, occupe actuellement le poste de Directeur des Opérations Régionales chez Ascension, supervisant des Unités Commerciales Horizontales à forte croissance. Son vaste expérience comprend des rôles de leadership chez des prestataires de soins de santé majeurs tels que Tenet Healthcare, Community Health Systems et HCA.
Dr. Sudhir Srivastava, Président et CEO de SS Innovations, a exprimé son enthousiasme quant à l'arrivée de M. Adams en cette période de croissance mondiale. L'entreprise a récemment lancé le SSI Mantra 3, un système robotique chirurgical avancé conçu pour un usage multisectoriel. SS Innovations recherche actuellement l'approbation de la FDA et prévoit de recevoir l'approbation marketing dans la deuxième moitié de 2025.
SS Innovations International, Inc. (OTC: SSII) hat die Ernennung von Tim Adams zu seinem Board of Directors als unabhängigen Direktor bekannt gegeben. Herr Adams ist ein Gesundheitsexecutive mit über 40 Jahren Erfahrung und derzeit Regional Operating Officer bei Ascension, wo er die wachstumsstarken horizontalen Geschäftseinheiten leitet. Sein umfangreicher Werdegang umfasst Führungspositionen bei großen Gesundheitsdienstleistern wie Tenet Healthcare, Community Health Systems und HCA.
Dr. Sudhir Srivastava, Vorsitzender und CEO von SS Innovations, äußerte Begeisterung über den Beitritt von Herrn Adams in einer Phase des globalen Wachstums. Das Unternehmen hat vor kurzem das SSI Mantra 3 auf den Markt gebracht, ein fortschrittliches chirurgisches Robotersystem, das für den Einsatz in mehreren Fachbereichen konzipiert ist. SS Innovations strebt derzeit die FDA-Zulassung an und erwartet, in der zweiten Hälfte von 2025 die Genehmigung für den Vertrieb zu erhalten.
- Addition of Tim Adams, a highly experienced healthcare executive, to the Board of Directors
- Launch of SSI Mantra 3, an advanced multi-specialty surgical robotic system
- FDA approval process underway with anticipated marketing approval in second half of 2025
- Potential for expanding into the US market and other global markets
- None.
Tim Adams to serve as Independent Board Director
FORT LAUDERDALE, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, is pleased to announce the addition of Mr. Tim Adams to its Board of Directors, where he will serve as an Independent Director.
Mr. Adams is a well-known and highly regarded healthcare executive with over 40 years of hospital operations experience. Since January 2018, he has occupied various executive positions with one of the largest healthcare providers in the United States. Since March 2024, he has served as a Regional Operating Officer with Ascension, where he oversees all of Ascension’s high growth Horizontal Business Units including ambulatory surgery centers, outpatient imaging, outpatient/inpatient physical therapy, pharmacy, urgent care, behavioral, and post-acute/at-home services. He joined Ascension in early 2018 initially serving as Market Chief Executive Officer for Ascension Tennessee. In January 2023, he was promoted to Senior Vice President/Regional Operating Officer, responsible for Ascension’s Florida, Indiana, Alabama, Kansas, Maryland, New York, Oklahoma, Tennessee and Texas ministry markets. For approximately six years prior to joining Ascension, Mr. Adams served as a Region Chief Executive Officer of one of the largest regions of Tenet Healthcare Corporation. Before that, he served in various senior executive positions with other for-profit hospital companies including Community Health Systems, HCA, IASIS and Health Management Associates. Mr. Adams also currently serves as Chairman of the Tennessee Hospital Association in addition to various other community boards. Given his extensive experience in the U.S. healthcare market, we believe that Mr. Adams will be a valuable member of our board of directors, especially as we look to obtain FDA approval to market and expand the sales of our system in the United States.
“I am very pleased that Tim will be joining us during the most robust phase of global growth to date, his appointment is perfectly timed. As a leader with some of the largest US hospital systems, Tim offers us a unique insight into the markets for our system and should prove invaluable as we enter the US and other markets around the world,” said Dr. Sudhir Srivastava, SS Innovations Chairman and CEO.
Mr. Adams added, “I am honored to have joined the Board of SS Innovations. The hospital sector, especially on the non-profit side, is a very thinly margined business and highly capital intensive. There is thus a tremendous opportunity to offer an alternative to existing surgical robotic solutions at a significantly lower price point that is still competitive in what it has to offer. I believe the SSI’s Mantra system does just that. I am also excited about the future potential of telesurgery and capabilities of the Mantra to meet those needs. The ability to leverage the particular skill set of a robotic surgeon over a large geography will be transformational. This could also have applications in the US where large health systems such as ours could eventually create surgical centers of excellence and leverage those centers across their enterprise along with their affiliated systems. This in turn would of course accelerate the need for robotic surgical systems. There is also tremendous opportunity to introduce an affordable robotic surgical system to the almost 10,000 and growing ambulatory surgery centers across the US.”
Earlier this year, SS Innovations launched the SSI Mantra 3, the newest and most advanced version of its surgical robotic system that makes possible more affordable and accessible surgical care across the globe.
The SSi Mantra 3 provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and telesurgery while engaging with surgeons and surgical teams to improve safety and efficiency during procedures. The regulatory approval process from the U.S. Food and Drug Administration (FDA) is already underway, and SS Innovations anticipates receiving approval to market in the second half of 2025.
About SS Innovations International, Inc.
SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s website at ssinnovations.com or LinkedIn for updates.
About SSi Mantra
Supporting advanced, affordable, and accessible robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi Mantra system has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India in more than 80 different types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving FDA approval to market and CE Mark approval in the second half of 2025.
Forward-Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations International’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Follow us on:
LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup/
YouTube: https://www.youtube.com/@ssinnovations
For media inquiries, please contact:
+1-212-739-0300
FAQ
Who is the new board member of SS Innovations (SSII)?
What is the latest product launched by SS Innovations (SSII)?
When does SS Innovations (SSII) expect FDA approval for their surgical robotic system?
What are the potential applications of SS Innovations' (SSII) Mantra system in healthcare?
